Skip to main content

Table 1 Characteristics of study participants

From: Patient and health facility attributes associated with retention and virologic suppression in private for-profit health facilities in Nigeria

 

Benue

FCT

Nasarawa

Combined

p-value

Sex, N (%)

Female

6977 (74.3)

3298 (67.4)

5325 (68.9)

15,600 (70.9)

 < 0.001*

Male

2415 (25.7)

1597 (32.6)

2403 (31.1)

6410 (29.1)

 

Age at ART start, mean (SD)

33.8 (10.4)

34.3 (9.4)

33.5 (9.5)

33.8 (9.9)

 < 0.001**

Pregnancy status†, N (%)

Not pregnant

6353 (91.1)

3069 (93.1)

5010 (94.1)

14,432 (92.5)

 < 0.001*

Pregnant

318 (4.6)

116 (3.5)

167 (3.1)

601 (3.9)

 

Breastfeeding

306 (4.4)

113 (3.4)

148 (2.8)

567 (3.6)

 

Duration on ART, N (%)

0–1 year

3452 (36.8)

1562 (31.9)

1993 (25.8)

7007 (31.8)

 < 0.001*

1–2 years

2831 (30.1)

1069 (21.9)

1505 (19.5)

5405 (24.6)

 

2–3 years

1782 (19.0)

940 (19.2)

1458 (18.9)

4180 (19.0)

 

3–4 years

882 (9.4)

583 (11.9)

1118 (14.5)

2583 (11.7)

 

4 + years

445 (4.5)

736 (15.1)

1654 (21.4)

2835 (12.9)

 

Baseline CD4 + count,

mean (SD)

385.5 (234.3)

374.5 (283.2)

362.1 (278.0)

374.5 (265.2)

 < 0.001**

ART regimen at start, N (%)

TDF based

8020 (85.4)

3634 (74.3)

6289 (81.4)

17,943 (81.5)

 < 0.001*

AZT based

1364 (14.5)

1241 (25.4)

1431 (18.5)

4036 (18.3)

 

Other

8 (0.1)

15 (0.3)

8 (0.1)

31 (0.1)

 

Current ART line, N (%)

1st line

9345 (99.5)

4811 (98.4)

7625 (98.7)

21,781 (99.0)

 < 0.001*

2nd line

47 (0.5)

79 (1.6)

103 (1.3)

229 (1.0)

 

ARV refill duration, N (%)

1 month

3489 (37.2)

2674 (54.7)

4049 (52.4)

10,212 (46.4)

 < 0.001*

2 months

4762 (50.7)

1568 (32.1)

2987 (38.7)

9317 (42.3)

 

3 + months

1141 (12.2)

648 (13.3)

692 (9.0)

2481 (11.3)

 

Contact tested, N (%)

No

174 (78.0)

3649 (83.5)

6230 (87.6)

10,052 (85.9)

 < 0.001*

Yes

49 (22)

719 (16.5)

882 (12.4)

1650 (14.1)

 

Facility support, N (%)

Standard

9392 (100)

2712 (55.5)

5122 (66.3)

17,226 (78.3)

 < 0.001*

Model§

0

2178 (44.5)

2606 (33.7)

4784 (21.7)

 

Total

9392 (42.7)

4890 (22.2)

7728 (35.1)

22010 (100)

 < 0.001*

  1. † Female patients only included in analysis
  2. ‡ Benue state ceded out of program to another implementer in 2018
  3. § Model facility support approach introduced in 2018 after sites in Benue had been ceded
  4. * P-value from Pearson’s Chi-squared test of proportions
  5. ** P-value from one-way ANOVA
Back to article page

AIDS Research and Therapy

ISSN: 1742-6405

Contact us